AKT1 and cancer: The combination of curcumin with compounds like AZD5363, AZD8542, and resveratrol exhibits synergistic effects, suppressing both the PI3K/AKT and SHH pathways, targeting multiple survival mechanisms in cancer cells and potentially enhancing cell death while reducing treatment resistance [90].